Dengue Vaccines Submitted to Health Sciences Authority for Consideration for Registration

Ms Sylvia Lim asked the Minister for Health (a) which of the dengue vaccine candidates submitted to the Health Sciences Authority (HSA) are under consideration for registration; and (b) what is the status of Takeda’s TAK-003 application to the HSA for registration as a dengue vaccine.

Takeda has withdrawn the application to register its dengue vaccine in Singapore following a review by the Health Sciences Authority (HSA) on its submitted scientific data. We note that the vaccine’s application was also withdrawn in the United States. At this point in time, there is no other application for registration of dengue vaccine to HSA. The Ministry of Health will continue to monitor the development of dengue vaccines as part of a multi-pronged approach to dengue control in Singapore.